Package 68083-343-05

Brand: cytarabine

Generic: cytarabine
NDC Package

Package Facts

Identity

Package NDC 68083-343-05
Digits Only 6808334305
Product NDC 68083-343
Product ID 68083-343_47628a16-dba0-4e55-ac61-70fc4d94730a
Description

5 VIAL, SINGLE-DOSE in 1 CARTON (68083-343-05) / 5 mL in 1 VIAL, SINGLE-DOSE (68083-343-01)

Marketing

Marketing Status
Marketed Since 2019-12-23
Brand cytarabine
Generic cytarabine
Sample Package No

Linked Drug Pages (1)

Cytarabine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRATHECAL", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "47628a16-dba0-4e55-ac61-70fc4d94730a", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["04079A1RDZ"], "rxcui": ["1731355"], "spl_set_id": ["7ab50348-ca78-46a5-aba6-c35b6b21fbfe"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Gland Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 VIAL, SINGLE-DOSE in 1 CARTON (68083-343-05)  / 5 mL in 1 VIAL, SINGLE-DOSE (68083-343-01)", "package_ndc": "68083-343-05", "marketing_start_date": "20191223"}], "brand_name": "Cytarabine", "product_id": "68083-343_47628a16-dba0-4e55-ac61-70fc4d94730a", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "68083-343", "generic_name": "Cytarabine", "labeler_name": "Gland Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cytarabine", "active_ingredients": [{"name": "CYTARABINE", "strength": "20 mg/mL"}], "application_number": "ANDA211937", "marketing_category": "ANDA", "marketing_start_date": "20191223", "listing_expiration_date": "20261231"}